LISATA THERAPEUTICS, INC. — Director's Dealing 2014

Dec 1, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2014-11-28

Reporting Person: MYERS STEVEN S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-28	Common stock, par value $0.001 per share	P	5000	$3.9892	Acquired	59331	Indirect
2014-12-01	Common stock, par value $0.001 per share	P	5000	$3.8495	Acquired	64331	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, par value $0.001 per share	123931	Direct
Common stock, par value $0.001 per share	8012	Indirect
Common stock, par value $0.001 per share	19531	Indirect